NEW YORK, July 30 (Reuters) - Roche Holding AG's eye disease drug Lucentis proved effective in helping to improve vision in patients suffering from a condition known as central retinal vein occlusion, ...
NEW YORK, Oct 4 (Reuters) - The optical drug Lucentis proved effective in two late-stage studies in improving the vision of patients with retinal vein occlusion as early as the seventh day of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback